Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc.
BIO
BIO
NYSE
Health Technology
Medical Specialties
305.96
USD
+4.26
+1.41%
Ditutup: 07-22 20:00 (UTC+0)
305.96
USD
+1.34
+0.44%
Pra-pasar: 07-23 08:26 (UTC+0)

BIO Statistik Utama

Tinggi
307.10
Buka
301.00
Volume
275.06K
Rendah
298.74
Cierre anterior
301.70
Nilai Perdagangan
84.03M
Tertinggi 52M
343.12
Volume relatif
0.897
Amplitudo (%)
2.77%
Terendah 52M
236.73
Tingkat Perputaran
1.27%
Kap Pasar
8.18B
P/E (TTM)
50.37
P/E (Tahunan)
10.978
P/B
1.2
P/S
3.16
Laba per Saham (EPS)
6.075
Dividen (TTM)
0
Imbal Hasil Dividen
0.00%
Saham beredar
21.70M
Mata uang
USD

BIO Kinerja Harga

7 hari
30 hari
90 hari
180 hari
Sejak awal tahun
1 Tahun
BIO Distribusi Arus Dana
BIO Volume Short Sale Harian
BIO Riwayat Short Interest
As of 2026-07-23, the Bio-Rad Laboratories, Inc. (BIO) stock price today is 305.96. Based on this price, the company has a market capitalization of $8.18B, with a P/E ratio of 50.37. On 2026-07-23, BIO traded between 298.74 and 307.10. Today’s stock price is 2.42% above the daily low and 0.37% below the daily high, placing BIO mendekati batas atas its most recent trading range. Trading volume currently stands at 275.06K, compared with an average daily volume of 306.76K. This suggests that trading activity is kira-kira sejalan dengan level biasanya than usual. Over the past year, Bio-Rad Laboratories, Inc. shares have traded between 236.73 and 343.12. At today’s price, BIO is 29.24% above its 52-week low and 10.83% below its 52-week high.
Nama Perusahaan
Bio-Rad Laboratories, Inc.
Sektor
Health Technology
Industri
Medical Specialties
Bursa
NYSE
Jumlah Karyawan
7,450
Ukuran Lot
40
Situs resmi
Mata uang
USD
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

BIO FAQ

Cari
Lebih